Back to Journals » Clinical Ophthalmology » Volume 13

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab

Total article views   HTML views PDF downloads Totals
7,178 Dovepress* 5,999+ 1,522 7,521
PubMed Central* 1,179 174 1,353
Totals 7,178 1,696 8,874
*Since 19 December 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar